Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Non-cash Items (2016 - 2025)

MediWound has reported Non-cash Items over the past 12 years, most recently at -$3.6 million for Q4 2025.

  • For Q4 2025, Non-cash Items rose 76.93% year-over-year to -$3.6 million; the TTM value through Dec 2025 reached -$3.6 million, up 76.93%, while the annual FY2025 figure was -$3.6 million, 123.27% down from the prior year.
  • Non-cash Items for Q4 2025 was -$3.6 million at MediWound, down from -$2.8 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $9.9 million in Q2 2024 and troughed at -$16.4 million in Q3 2024.
  • A 5-year average of -$1.2 million and a median of -$611000.0 in 2022 define the central range for Non-cash Items.
  • On a YoY basis, Non-cash Items climbed as much as 331.97% in 2024 and fell as far as 2639.04% in 2024.
  • Year by year, Non-cash Items stood at $2.1 million in 2021, then crashed by 303.57% to -$4.3 million in 2022, then skyrocketed by 229.64% to $5.5 million in 2023, then tumbled by 379.01% to -$15.5 million in 2024, then surged by 76.93% to -$3.6 million in 2025.
  • Business Quant data shows Non-cash Items for MDWD at -$3.6 million in Q4 2025, -$2.8 million in Q3 2025, and $8.7 million in Q2 2025.